Cargando…
An assessment of the efficacy and safety of dydrogesterone in women with ovarian endometrioma: An open‐label multicenter clinical study
PURPOSE: To assess the efficacy and safety of dydrogesterone in Japanese women with ovarian endometrioma in a real‐world setting. METHODS: The post‐marketing study involved 15 sites in Japan. Dydrogesterone 10 mg twice daily orally was administered for 21 days (day 5‐25 of each menstrual cycle) for...
Autores principales: | Kitawaki, Jo, Koga, Kaori, Kanzo, Takumi, Momoeda, Mikio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254175/ https://www.ncbi.nlm.nih.gov/pubmed/34262403 http://dx.doi.org/10.1002/rmb2.12391 |
Ejemplares similares
-
Efficacy and safety of a flexible extended regimen of ethinylestradiol/drospirenone for the treatment of dysmenorrhea: a multicenter, randomized, open-label, active-controlled study
por: Momoeda, Mikio, et al.
Publicado: (2017) -
Clinical practice guidelines for endometriosis in Japan (The 3rd edition)
por: Harada, Tasuku, et al.
Publicado: (2022) -
Contralateral ovarian endometrioma recurrence after unilateral salpingo-oophorectomy
por: Hidari, Tokie, et al.
Publicado: (2019) -
Cost-effectiveness of the recommended medical intervention for the treatment of dysmenorrhea and endometriosis in Japan
por: Arakawa, Ichiro, et al.
Publicado: (2018) -
The efficacy of dydrogesterone use to suppress premature luteinizing hormone surge on cycle outcomes in controlled ovarian stimulation
por: Doğan Durdağ, Gülşen, et al.
Publicado: (2021)